טוען...
Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis
IMPORTANCE: Before using brain volume loss (BVL) as a marker of therapeutic response in multiple sclerosis (MS), certain biological and methodological issues must be clarified. OBJECTIVES: To assess the dynamics of BVL as MS progresses and to evaluate the repeatability and exchangeability of BVL est...
שמור ב:
| הוצא לאור ב: | JAMA Neurol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Medical Association
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6233851/ https://ncbi.nlm.nih.gov/pubmed/29971335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2018.1596 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|